Her primary scientific interests are in Radiation therapy, Immunotherapy, Immune system, Immunology and Abscopal effect. The study incorporates disciplines such as CTLA-4, Cancer research, Lung cancer and Antigen in addition to Radiation therapy. Her study looks at the relationship between Immunotherapy and topics such as Combined Modality Therapy, which overlap with Neoplasms therapy.
In her research, CD8 and Transforming growth factor beta is intimately related to Blockade, which falls under the overarching field of Immune system. Her work carried out in the field of Abscopal effect brings together such families of science as Dose fractionation, Ionizing radiation, Oncology and Pathology. Her Oncology research incorporates elements of Clinical trial, Carcinoma, Dosing, Biomarker and Breast cancer.
Sandra Demaria focuses on Cancer research, Immunotherapy, Immunology, Immune system and Radiation therapy. Her studies deal with areas such as Cancer cell, Blockade, CD8, Breast cancer and Antibody as well as Cancer research. Her Immunotherapy study incorporates themes from Tumor microenvironment, T cell and Cytotoxic T cell.
Her biological study deals with issues like Antigen, which deal with fields such as Molecular biology and Receptor. Her Radiation therapy research incorporates themes from Abscopal effect, Ipilimumab and Oncology. Sandra Demaria interconnects Biomarker, Clinical trial, Tumor-infiltrating lymphocytes and Triple-negative breast cancer in the investigation of issues within Oncology.
Her primary areas of investigation include Immune system, Cancer research, Internal medicine, Oncology and Radiation therapy. The subject of her Immune system research is within the realm of Immunology. Her Cancer research research is multidisciplinary, relying on both Cancer cell, Cancer, Tumor microenvironment, CD8 and Cytotoxic T cell.
Her Oncology research is multidisciplinary, incorporating perspectives in Peripheral blood mononuclear cell and Personalized therapy. Her biological study spans a wide range of topics, including Adjuvant, Immunotherapy, MHC class I, Colorectal cancer and Effector. Sandra Demaria combines subjects such as Blockade, Adverse effect, MEDLINE and Intensive care medicine with her study of Immunotherapy.
The scientist’s investigation covers issues in Internal medicine, Oncology, Breast cancer, Cancer and Cancer research. Her study in Breast cancer is interdisciplinary in nature, drawing from both Chemotherapy regimen, Stromal tumor and Cancer immunology. The Cancer research study combines topics in areas such as Immune checkpoint, Cancer cell, Immune system and Cytotoxic T cell, Antigen presentation.
Cancer cell connects with themes related to Abscopal effect in her study. Her Immune system research includes themes of Cancer treatment, Radiation therapy and Omics. Sandra Demaria works mostly in the field of Radiation therapy, limiting it down to topics relating to Myeloid-derived Suppressor Cell and, in certain cases, Immunotherapy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R. Salgado;R. Salgado;C. Denkert;S. Demaria;N. Sirtaine.
Annals of Oncology (2015)
Fractionated but not single dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody
M. Zahidunnabi Dewan;Ashley E. Galloway;Noriko Kawashima;J. Keith Dewyngaert.
Clinical Cancer Research (2009)
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated
Sandra Demaria;Bruce Ng;Mary Louise Devitt;James S Babb.
International Journal of Radiation Oncology Biology Physics (2004)
Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
Sylvia Adams;Robert J. Gray;Sandra Demaria;Lori Goldstein.
Journal of Clinical Oncology (2014)
Immune-Mediated Inhibition of Metastases after Treatment with Local Radiation and CTLA-4 Blockade in a Mouse Model of Breast Cancer
Sandra Demaria;Noriko Kawashima;Anne Marie Yang;Mary Louise Devitt.
Clinical Cancer Research (2005)
Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift
Silvia C. Formenti;Sandra Demaria.
Journal of the National Cancer Institute (2013)
Systemic effects of local radiotherapy
Silvia C Formenti;Sandra Demaria.
Lancet Oncology (2009)
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity.
Claire Vanpouille-Box;Amandine Alard;Amandine Alard;Molykutty J. Aryankalayil;Yasmeen Sarfraz.
Nature Communications (2017)
An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non-Small Cell Lung Cancer
Encouse B. Golden;Sandra Demaria;Peter B. Schiff;Abraham Chachoua.
Cancer immunology research (2013)
Consensus guidelines for the detection of immunogenic cell death
Oliver Kepp;Laura Senovilla;Ilio Vitale;Erika Vacchelli.
OncoImmunology (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Cornell University
Peter MacCallum Cancer Centre
Cornell University
Philipp University of Marburg
University of Paris-Saclay
Yale University
University of Milan
European Institute of Oncology
National Institutes of Health
New York University
Centre national de la recherche scientifique, CNRS
North Carolina State University
Texas Christian University
Imperial College London
Goethe University Frankfurt
Washington University in St. Louis
Instituto Ramón y Cajal de Investigación Sanitaria
Aix-Marseille University
Sorbonne University
National University of Ireland, Galway
Teagasc - The Irish Agriculture and Food Development Authority
Inserm : Institut national de la santé et de la recherche médicale
University College London
Universidade de São Paulo
University of Tasmania
University of California, Berkeley